METROPOLITAN LIFE INSURANCE CO/NY - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$86,217
-5.0%
12,212
-15.7%
0.00%0.0%
Q4 2020$90,720
+15.2%
14,492
-0.4%
0.00%0.0%
Q3 2020$78,748
+1.7%
14,556
-1.8%
0.00%0.0%
Q2 2020$77,402
-45.9%
14,828
+0.5%
0.00%
-66.7%
Q3 2018$143,172
-99.9%
14,7600.0%0.00%
+50.0%
Q2 2018$150,552,000
+42.4%
14,760
+81.4%
0.00%
+100.0%
Q1 2018$105,755,000
+72334.9%
8,1350.0%0.00%
-50.0%
Q4 2017$146,000
-62.1%
8,135
-46.9%
0.00%0.0%
Q3 2017$385,000
+4.3%
15,3290.0%0.00%
-33.3%
Q2 2017$369,000
+79.1%
15,329
+43.2%
0.00%
+200.0%
Q1 2017$206,000
+24.8%
10,7050.0%0.00%0.0%
Q4 2016$165,000
+9.3%
10,705
-8.0%
0.00%0.0%
Q3 2016$151,000
+2.0%
11,641
+9.7%
0.00%0.0%
Q2 2016$148,000
+5.7%
10,613
+15.3%
0.00%0.0%
Q1 2016$140,000
-20.0%
9,2020.0%0.00%0.0%
Q4 2015$175,0000.0%9,2020.0%0.00%0.0%
Q3 2015$175,000
-26.2%
9,2020.0%0.00%
-50.0%
Q2 2015$237,0009,2020.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$13,340,0009.89%
Abingworth LLP 1,041,131$5,341,0004.85%
Roumell Asset Management, LLC 450,406$2,311,0004.78%
HIGHLAND CAPITAL MANAGEMENT LP 2,391,993$12,271,0000.94%
Trellus Management Company, LLC 71,200$365,0000.82%
ARMISTICE CAPITAL, LLC 1,968,000$10,096,0000.76%
Arbiter Partners Capital Management LLC 1,111,936$5,704,0000.64%
Fortress Investment Group LLC 433,804$2,226,0000.27%
GENERAL AMERICAN INVESTORS CO INC 464,985$2,385,0000.25%
WATER ISLAND CAPITAL LLC 318,518$1,634,0000.12%
View complete list of PARATEK PHARMACEUTICALS INC shareholders